130 related articles for article (PubMed ID: 2512229)
1. [Allogeneic bone marrow transplantation in multiple myeloma].
Bandini G; Rosti G; Cavo M; Albertazzi L; Rizzi S; Motta MR; Gobbi M; Tassi C; Tazzari PL; Miggiano C
Haematologica; 1989 Oct; 74(5 Suppl):463-72. PubMed ID: 2512229
[No Abstract] [Full Text] [Related]
2. High-dose busulfan and cyclophosphamide are an effective conditioning regimen for allogeneic bone marrow transplantation in chemosensitive multiple myeloma.
Cavo M; Bandini G; Benni M; Gozzetti A; Ronconi S; Rosti G; Zamagni E; Lemoli RM; Bonini A; Belardinelli A; Motta MR; Rizzi S; Tura S
Bone Marrow Transplant; 1998 Jul; 22(1):27-32. PubMed ID: 9678792
[TBL] [Abstract][Full Text] [Related]
3. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.
Atanackovic D; Cao Y; Luetkens T; Panse J; Faltz C; Arfsten J; Bartels K; Wolschke C; Eiermann T; Zander AR; Fehse B; Bokemeyer C; Kroger N
Haematologica; 2008 Mar; 93(3):423-30. PubMed ID: 18287134
[TBL] [Abstract][Full Text] [Related]
4. Allogeneic bone marrow transplantation for multiple myeloma.
Ballester OF
Semin Oncol; 1993 Oct; 20(5 Suppl 6):67-71. PubMed ID: 8211218
[TBL] [Abstract][Full Text] [Related]
5. [Intensive treatment of multiple myeloma].
Harousseau JL
Bull Acad Natl Med; 2003; 187(2):405-13; discussion 413-5. PubMed ID: 14556449
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic transplantation for multiple myeloma: further evidence for a GVHD-associated graft-versus-myeloma effect.
Le Blanc R; Montminy-Métivier S; Bélanger R; Busque L; Fish D; Roy DC; Kassis J; Boileau J; Lavallée R; Bélanger D; Letendre F; Hébert J; Sauvageau G; Perreault C; Roy J
Bone Marrow Transplant; 2001 Nov; 28(9):841-8. PubMed ID: 11781644
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic bone marrow transplantation in multiple myeloma using HLA-compatible sibling donors--an EBMT Registry Study.
Gahrton G; Tura S; Ljungman P; Belanger B; Brandt L; Cavo M; Chapuis B; De Laurenzi A; de Witte T; Facon T
Bone Marrow Transplant; 1991; 7 Suppl 2():32. PubMed ID: 1878706
[No Abstract] [Full Text] [Related]
8. Allogenic BMT for multiple myeloma (MM). The Italian experience.
Cavo M; Tura S; Rosti G; Grimaldi M; Bandini G; Bonelli MA; Calori E; Rizzi S; Van Lint MT; Bacigalupo A
Bone Marrow Transplant; 1991; 7 Suppl 2():31. PubMed ID: 1878705
[No Abstract] [Full Text] [Related]
9. VAMP followed by high dose melphalan and autologous bone marrow transplantation for multiple myeloma.
McElwain TJ; Gore ME; Meldrum M; Viner C; Judson IR; Malpas JS
Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():109-12. PubMed ID: 2697419
[TBL] [Abstract][Full Text] [Related]
10. Intensive therapy for high grade multiple myeloma (MM).
Harousseau JL; Milpied N; Jouet JP; Colombat P; Guilhot F; Laporte JP; Ifrah N; Gandhour C; Casassus P
Bone Marrow Transplant; 1991; 7 Suppl 2():28. PubMed ID: 1878703
[No Abstract] [Full Text] [Related]
11. Bulbar palsy in multiple myeloma.
Chim CS; Ooi GC
Haematologica; 2005 Dec; 90(12 Suppl):ECR42. PubMed ID: 16464757
[No Abstract] [Full Text] [Related]
12. A randomized placebo-controlled trial of lisofylline in HLA-identical, sibling-donor, allogeneic bone marrow transplant recipients. The Lisofylline Marrow Transplant Study Group.
List AF; Maziarz R; Stiff P; Jansen J; Liesveld J; Andrews F; Schuster M; Wolff S; Litzow M; Karanes C; Dahlberg S; Kirkhart B; Bianco JA; Singer JW
Bone Marrow Transplant; 2000 Feb; 25(3):283-91. PubMed ID: 10673700
[TBL] [Abstract][Full Text] [Related]
13. High-dose therapy with autologous or allogeneic transplantation as salvage therapy for small cleaved cell lymphoma of follicular center cell origin.
Stein RS; Greer JP; Goodman S; Kallianpur A; Ahmed MS; Wolff SN
Bone Marrow Transplant; 1999 Feb; 23(3):227-33. PubMed ID: 10084253
[TBL] [Abstract][Full Text] [Related]
14. Transplantation as salvage therapy for high-risk patients with myeloma in relapse.
Lee CK; Barlogie B; Zangari M; Fassas A; Anaissie E; Morris C; Van Rhee F; Cottler-Fox M; Thertulien R; Muwalla F; Mazher S; Badros A; Tricot G
Bone Marrow Transplant; 2002 Dec; 30(12):873-8. PubMed ID: 12476279
[TBL] [Abstract][Full Text] [Related]
15. Autologous bone marrow transplantation with immunotoxin purged marrow for multiple myeloma. Long term results in 14 patients with advanced disease.
Gobbi M; Tazzari PL; Cavo M; Tassi C; Grimaldi M; Meloni G; Di Nucci G; Vignetti M; Bolognesi A; Stirpe F
Bone Marrow Transplant; 1991; 7 Suppl 2():30. PubMed ID: 1878704
[No Abstract] [Full Text] [Related]
16. [Autotransplantation in acute leukemia].
Rizzoli V; Mangoni L; Carlo-Stella C; Bonati A
Haematologica; 1989 Oct; 74(5 Suppl):24-48. PubMed ID: 2512210
[No Abstract] [Full Text] [Related]
17. [Advances in treatment of multiple myeloma].
Gola A
Acta Haematol Pol; 1992; 23(4):229-35. PubMed ID: 1293903
[TBL] [Abstract][Full Text] [Related]
18. Treatment of myeloma using intensive therapy and allogeneic bone marrow transplantation.
Reece DE; Shepherd JD; Klingemann HG; Sutherland HJ; Nantel SH; Barnett MJ; Spinelli JJ; Phillips GL
Bone Marrow Transplant; 1995 Jan; 15(1):117-23. PubMed ID: 7742743
[TBL] [Abstract][Full Text] [Related]
19. Prevention of graft-versus-host disease in high risk patients by depletion of CD4+ and reduction of CD8+ lymphocytes in the marrow graft.
Herrera C; Torres A; García-Castellano JM; Roman J; Martin C; Serrano J; Falcon M; Alvarez MA; Gomez P; Martinez F
Bone Marrow Transplant; 1999 Mar; 23(5):443-50. PubMed ID: 10100557
[TBL] [Abstract][Full Text] [Related]
20. Comparison of autologous bone marrow transplantation and peripheral blood stem cell transplantation after first remission induction treatment in multiple myeloma.
Harousseau JL; Attal M; Divine M; Milpied N; Marit G; Leblond V; Stoppa AM; Bourhis JH; Caillot D; Boasson M
Bone Marrow Transplant; 1995 Jun; 15(6):963-9. PubMed ID: 7581098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
